PATENT CLAIM ANALYSIS

Application Number: 16038603
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "002400"]

Abstract:
The present invention relates to peptidomimetics of the formula (I) or (I)c wherein L 1 , L 2 , L 3 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , n, m, Q, X, Z 1  and Z 2  are defined as mentioned in the description and to salts and solvates of each of these compounds and to processes for the preparation thereof, compositions containing them and the uses of such compounds. It has been found that the compounds have a high microbicide activity and are suited to combat resistant bacteria, such as meticillin-resistant  Staphylococcus aureus  (MRSA) strains, at very low concentrations.

Claim (Index 19):
The method of claim  1 , wherein the bacterial infection is caused by bacteria that have gained a resistance against the penicillin-type antibiotics or vancomycin.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.72973
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15104186', '10602521', '10683756', '11807927', '10473443']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7909753165724256
- 35 USC 102 Novelty (BERT): 0.5714343940215021
- Combined Prediction Score: 0.7690212243173332
- Mean Citation Score: 359.98138600000016
- Max Citation Score: 630.2693
- Similarity Product: 333.14707665156726

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test